$Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature$
Código QR

Código QR

Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature

Jun Iwamoto1, Yoshihiro Sato2, Tsuyoshi Takeda1, Hideo Matsumoto21Department of Sports Medicine, Keio University School of Medicine, Tokyo, Japan; 2Department of Neurology, Mitate Hospital, Fukuoka, JapanAbstract: Osteoporosis most commonly affects postmenopausal women, placing them at a significant...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jun Iwamoto, Yoshihiro Sato, Tsuyoshi Takeda, Hideo Matsumoto
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2008
Materias:	Hip fracture Bone turnover Bone mineral density (BMD) Cortical Porosity Cortical thickness Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/f131d1b118c042ae982f98a99b3a03ae
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Analysis of three-dimensional bone mineral density and bone strength measured by quantitative computed tomography following denosumab discontinuation in a patient with postmenopausal osteoporosis
por: Tsuchiya K, et al.
Publicado: (2019)

Educational program for orthopedic surgeons’ influences for osteoporosis
por: Zhuang Huafeng, et al.
Publicado: (2021)

Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links
por: Fisher A, et al.
Publicado: (2013)

Editorial: Osteoporosis in Rheumatic Diseases, What's New?
por: Barbara Ruaro, et al.
Publicado: (2021)

Pore‐Size Distribution and Frequency‐Dependent Attenuation in Human Cortical Tibia Bone Discriminate Fragility Fractures in Postmenopausal Women With Low Bone Mineral Density
por: Gabriele Armbrecht, et al.
Publicado: (2021)

Discontinuation of PTH therapy amplifies bone loss by increasing oxidative stress: An event ameliorated by sequential IL-17 neutralizing antibody therapy
por: Krishna Bhan Singh, et al.
Publicado: (2022)

Plasma homocysteine level is a risk factor for osteoporotic fractures in elderly patients
por: Zhu Y, et al.
Publicado: (2016)

Utility of fragility fracture prediction tools in a group of postmenopausal women
por: Jarosław Amarowicz, et al.
Publicado: (2021)

Additive effects of nutritional supplementation, together with bisphosphonates, on bone mineral density after hip fracture: a 12-month randomized controlled study
por: Flodin L, et al.
Publicado: (2014)

Constitutive modeling of cortical bone considering anisotropic inelasticity and damage evolution
por: Noritoshi ATSUMI, et al.
Publicado: (2017)

The Associations of Serum Vitamin D and Bone Turnover Markers with the Type and Severity of Hip Fractures in Older Women
por: Zhao J, et al.
Publicado: (2020)

Relationship between abnormal glucose metabolism and osteoporosis in Han Chinese men over the age of 50 years
por: Liu M, et al.
Publicado: (2019)

Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
por: Mederle OA, et al.
Publicado: (2018)

Correlations between sleep disturbance and brain cortical morphometry in healthy children
por: Xiaoxu Na, et al.
Publicado: (2021)

The relationships between bone turnover markers and bone mineral density in postmenopausal type 2 diabetic women
por: Vadim V. Klimontov, et al.
Publicado: (2016)

Transient Osteoporosis of the Hip: Risk and Therapy
por: Bashaireh KM, et al.
Publicado: (2020)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
por: Tahir Masud, et al.
Publicado: (2009)

Screen Time and Bone Status in Children and Adolescents: A Systematic Review
por: Carmela de Lamas, et al.
Publicado: (2021)

Eldecalcitol for the treatment of osteoporosis
por: Noguchi Y, et al.
Publicado: (2013)

Micro-Implanted-Anchorage Safety: Cortical Bone Thickness in the Maxillary Posterior Region of Skeletal Class II Malocclusion
por: Li,Shi-Feng, et al.
Publicado: (2018)

Validation of three tools for identifying painful new osteoporotic vertebral fractures in older Chinese men: bone mineral density, Osteoporosis Self-Assessment Tool for Asians, and fracture risk assessment tool
por: Lin JS, et al.
Publicado: (2016)

Potential role of odanacatib in the treatment of osteoporosis
por: Ng KW
Publicado: (2012)

Gut microbiota is associated with bone mineral density: an observational and genome-wide environmental interaction analysis in the UK Biobank cohort
por: Bolun Cheng, et al.
Publicado: (2021)

Reducing hip fractures in the elderly
por: Victoria Leytin, et al.
Publicado: (2011)

Vertical Guided Bone Regeneration in the Rabbit Calvarium Using Porous Nanohydroxyapatite Block Grafts Coated with rhVEGF165 and Cortical Perforation
por: Liu W, et al.
Publicado: (2020)

Correlation between bone mineral density and serum trace elements in response to supervised aerobic training in older adults
por: Alghadir AH, et al.
Publicado: (2016)

Fractures in the elderly: when is hip replacement a necessity?
por: Prasad Antapur, et al.
Publicado: (2010)

Understanding and Managing Corticosteroid-Induced Osteoporosis
por: Kobza AO, et al.
Publicado: (2021)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
por: Fujiwara S, et al.
Publicado: (2014)

Pathophysiology of Vascular Calcification and Bone Loss: Linked Disorders of Ageing?
por: Jorge B. Cannata-Andía, et al.
Publicado: (2021)

Depression and geriatric assessment in older people admitted for hip fracture
por: Charles-Lozoya,Sergio, et al.
Publicado: (2019)

Divergent effects of obesity on fragility fractures
por: Caffarelli C, et al.
Publicado: (2014)

Repeated vertebral augmentation for new vertebral compression fractures of postvertebral augmentation patients: a nationwide cohort study – how useful is the current clinical gold standard for fracture risk?
por: Wilson HCP, et al.
Publicado: (2015)

Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
por: Luigi Gennari, et al.
Publicado: (2010)

CKD Stages, Bone Metabolism Markers, and Cortical Porosity Index: Associations and Mediation Effects Analysis
por: Yan Xiong, et al.
Publicado: (2021)

Amaurosis bilateral cortical en preeclampsia severa
por: Adauy E.,Arlette, et al.
Publicado: (2004)

Senile osteoporosis: Modern view of the problem
por: V.S. Shapovalov, et al.
Publicado: (2021)

Effects of teriparatide in Chinese and Caucasian women with osteoporosis: bridging study on efficacy
por: Xie Z, et al.
Publicado: (2019)

Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis
por: Masashi Uehara, et al.
Publicado: (2021)

Relationship Between Serum Amino Acid Levels and Bone Mineral Density: A Mendelian Randomization Study
por: Zhiyong Cui, et al.
Publicado: (2021)